Inhibition of BATF/JUN transcriptional activity protects against osteoarthritic cartilage destruction

Jinseol Rhee1, Seo-Hee Park1, Seul-Ki Kim1

  • 1School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.

Abstract

Insights

The basic leucine zipper transcription factor, ATF-like (BATF), regulates genes involved in osteoarthritis (OA) cartilage destruction. Inhibiting BATF/JUN complexes offers a potential therapeutic strategy for OA.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Rheumatology

Background:

  • The basic leucine zipper transcription factor, ATF-like (BATF), is an Activator protein-1 family member.
  • BATF's function is context-dependent, influenced by its interacting partners, JUN-B or C-JUN.
  • Its role in chondrocyte gene regulation and osteoarthritis (OA) pathogenesis requires elucidation.

Purpose of the Study:

  • To investigate the regulatory effects of the BATF/JUN complex on catabolic and anabolic gene expression in chondrocytes.
  • To determine the contribution of BATF/JUN to osteoarthritis (OA) pathogenesis.

Main Methods:

  • Primary mouse chondrocytes were treated with pro-inflammatory cytokines or infected with Ad-Batf.
  • BATF and JUN expression was analyzed in human and mouse OA cartilage.
  • Experimental OA was induced in mice via destabilization of the medial meniscus or Ad-Batf injection.
  • Chromatin immunoprecipitation assays examined BATF/JUN binding to candidate gene promoters.

Main Results:

  • BATF overexpression, forming complexes with JUN-B and C-JUN, upregulated matrix-degrading enzymes and downregulated cartilage matrix molecules.
  • BATF expression in mouse joints exacerbated OA cartilage destruction; Batf knockout suppressed experimental OA.
  • Pharmacological inhibition of BATF/JUN activity reduced matrix-degrading enzyme expression and protected against experimental OA.

Conclusions:

  • BATF/JUN-B and BATF/C-JUN complexes are crucial in OA cartilage destruction by modulating chondrocyte gene expression.
  • BATF represents a promising therapeutic target for osteoarthritis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K